Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On December 11, 2012, R. Scott Etlinger resigned his position as Senior Vice President—Global Operations of AngioDynamics, Inc. (the “Company”), effective December 28, 2012. Mr. Etlinger will not receive any severance or termination payments from the Company in connection with his resignation.
On December 17, 2012, the Company appointed George W. Bourne as Senior Vice President and Chief Technology & Operations Officer. Previously Mr. Bourne, age 52, was Senior Vice President and Chief Technology Officer for the Company, joining in May, 2012. Prior to joining AngioDynamics, Mr. Bourne served as VP of R&D at Hologic, and before this served as Senior Vice President of R&D and Clinical Affairs for Navilyst Medical from its formation in early 2008 until November 2011. His tenure was defined by focused portfolio development and the commercialization of new products. He also served 10 years at Boston Scientific as Vice President, R&D, of the Urology, Meditech and Oncology business units and then as Group Vice President, R&D, for the endosurgery business group. Mr. Bourne earned his Bachelor of Science in Biological Science and Master of Science in Plastics Engineering from the University of Lowell, in addition to his MBA from Rivier College in Nashua, N.H. He also served in leadership positions at Baxter Healthcare, Allegiance Healthcare and C.R. Bard.
A copy of the press release pursuant to which the Company announced the appointment of Mr. Bourne is filed as Exhibit 99.1 to this Current Report on Form 8-K.
Item 9.01. Financial Statements and Exhibits.
Press release dated December 17, 2012